Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Ret Proto-Oncogene antibody (AA 702-848)

The Mouse Monoclonal anti-Ret Proto-Oncogene antibody (Clone RET-2975) (ABIN7860598) specifically detects Ret Proto-Oncogene in IHC. The antibody is reactive with Human samples.
Catalog No. ABIN7860598
$595.63
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Ret Proto-Oncogene antibody (AA 702-848) (ABIN7860598)

Target

See all Ret Proto-Oncogene (RET) Antibodies
Ret Proto-Oncogene (RET)

Reactivity

  • 228
  • 109
  • 83
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 190
  • 89
  • 2
  • 2
  • 1
Mouse

Clonality

  • 176
  • 108
Monoclonal

Conjugate

  • 142
  • 16
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This Ret Proto-Oncogene antibody is un-conjugated

Application

  • 183
  • 92
  • 85
  • 65
  • 65
  • 46
  • 27
  • 26
  • 21
  • 17
  • 14
  • 10
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

RET-2975
  • Binding Specificity

    • 65
    • 20
    • 18
    • 15
    • 15
    • 15
    • 12
    • 9
    • 9
    • 8
    • 8
    • 8
    • 8
    • 6
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 702-848

    Purpose

    RET Proto-oncogene Antibody

    Specificity

    The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system, in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney. 79oΩAlterations in RET 79oΩgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung s disease.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 702-848) of human RET protein (exact sequence is proprietary)

    Isotype

    IgG1, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    Ret Proto-Oncogene (RET)

    Alternative Name

    RET Proto-oncogene

    Background

    Cadherin family member 12 (CDHF12), Cadherin related family member 16 (CDHR16), ELKS, HSCR1, Hydroxyaryl protein kinase, MEN2A, MEN2B, MTC1, Multiple endocrine neoplasia and medullary thyroid carcinoma 1, Oncogene RET, Proto-oncogene c-Ret, Proto-oncogene tyrosine-protein kinase receptor ret, PTC, RET, RET ELE1, RET51, RET9

    colon or prostate carcinoma.|Human breast

    Molecular Weight

    150kDa (precursor), 170kDa (Mature)

    Gene ID

    5979, 350321

    UniProt

    P07949

    Pathways

    RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
You are here:
Chat with us!